Surprisingly, the parental B16F10 cells express high levels of stem cell markers, CD44, CD166, whereas the B16F10-sMICB cells presented a heterogenic population in the expression of CD44 and CD166 (Figure 5C), which potentially reflected the heterogenic tumor incidence in vivo as presented in Figure 1. Here, CD44 is linked to neoplasm.